Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

The Clinical Utility of FDG PET-CT in Evaluation of Bone Marrow Involvement by Diffuse Large B Cell Lymphoma

Hyo Jung Kim, M.D., Ph.D., Boram Han, M.D., Dok Hyun Yoon, M.D, Ho Young Kim, M.D., Shin Kim, R.N, Min Young Kang, R.N., Hee Sung Hwang, M.D., Young Kyung Lee, M.D., Ph.D, Dae Young Zang, M.D. Ph.D., Cheolwon Suh, M.D., Ph.D.

Blood (2011) 118 (21): 2661.

https://doi.org/10.1182/blood.V118.21.2661.2661

Published: 2011

Journal Articles

Remobilization with High Dose Methotrexate and Cytarabine in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma Previously Failing Mobilization with Chemotherapy and Cytokine Treatment

Seong Joon Park, M.D, Dok Hyun Yoon, Shin Kim, R.N, Cheolwon Suh, M.D., Ph.D.

Blood (2011) 118 (21): 4402.

https://doi.org/10.1182/blood.V118.21.4402.4402

Published: 2011

Journal Articles

SIGNIFICANCE of ABSOLUTE LYMPHOCYTE COUNT at RELAPSE as a PROGNOSTIC FACTOR in PATIENTS with T-CELL NON-HODGKIN'S LYMPHOMA.

Dae Ro Choi, M.D., Dok Hyun Yoon, M.D., Heui June Ahn, M.D., Yoojin Cho, M.D., Eun Kyoung Kim, M.D., Shin Kim, Jooryung Huh, M.D., Dae Ho Lee, M.D., Sang We Kim, M.D., Jung Shin Lee, M.D., Cheolwon Suh, M.D.

Blood (2009) 114 (22): 2939.

https://doi.org/10.1182/blood.V114.22.2939.2939

Published: 2009

Journal Articles

Myelomatous Pleural Effusion of Multiple Myeloma: Characteristics and Outcome.

Hyo Jung Kim, M.D., Ph.D., Dae Ro Choi, M.D., Gak-Won Yun, M.D., Eunkyung Park, M.D., Ph.D., Seok Jin Kim, MD, PhD, Young Kyung Lee, M.D., Ph.D., Jong-Ho Won, M.D., Ph.D., Sung-Soo Yoon, M.D., Ph.D., Cheolwon Suh, M.D., Ph.D., Korean Multiple Myeloma Working Party, (KMMWP)

Blood (2009) 114 (22): 3874.

https://doi.org/10.1182/blood.V114.22.3874.3874

Published: 2009

Journal Articles

Excessive Toxicity of Once Daily Intravenous Busulfan, Melphalan, and Thiotepa Followed by Autologous Stem Cell Transplantation On Patients with Non-Hodgkin's Lymphoma.

Jong-Ho Won, M.D., Ph.D., Sang-Cheol Lee, M.D., Seok Jin Kim, M.D., Ph.D., Dae Ho Lee, M.D., Ph.D., Won Seog Kim, M.D., Ph.D., Cheolwon Suh, M.D., Ph.D., Hee-Sook Park, M.D., Ph.D.

Blood (2009) 114 (22): 4361.

https://doi.org/10.1182/blood.V114.22.4361.4361

Published: 2009

Journal Articles

The Role of High Dose Chemotherapy/Autologous Stem Cell Transplantation for Salvage Treatment for Relapsed Peripheral T Cell Lymphoma.

Yoojin Cho, MD, Myoung Joo Kang, MD, Dae Ro Choi, MD, Eun Kyoung Kim, MD, Shin Kim, Dae Ho Lee, MD, Sang We Kim, MD, Jooryung Huh, MD, Jeong Shin Lee, MD, Cheolwon Suh, M.D.

Blood (2009) 114 (22): 4363.

https://doi.org/10.1182/blood.V114.22.4363.4363

Published: 2009

Journal Articles

Clinical Features and Prognostic Relevance of Ovarian Involvement in Non-Hodgkin's Lymphoma: a Consortium for Improving Survival of Lymphoma (CISL) Report.

Jina Yoon, Seok Jin Kim, MD, PhD, Jong Ho Won, Chul Won Choi, MD, PhD, Hyeon-Seok Eom, Jin Seok Kim, Min Kyoung Kim, Jae-Yong Kwak, Won Seog Kim, Cheolwon Suh, M.D.

Blood (2009) 114 (22): 4999.

https://doi.org/10.1182/blood.V114.22.4999.4999

Published: 2009

Journal Articles

The Utility of the Follow-up with Serum Free Light Chain After Autologous Stem Cell Transplantation in Multiple Myeloma Patients with Measurable M-Protein.

Byeong Seok Sohn, M.D., Eun Kyoung Kim, M.D., Dok Hyun Yoon, M.D., Myoung Joo Kang, M.D., Dae Ro Choi, M.D., Heui June Ahn, M.D., Yoo Jin Cho, M.D., Kyu-pyo Kim, M.D., Dae Ho Lee, M.D., Sang We Kim, M.D., Cheolwon Suh, M.D., Jung Shin Lee, M.D.

Blood (2009) 114 (22): 4878.

https://doi.org/10.1182/blood.V114.22.4878.4878

Published: 2009

Journal Articles

Primary Mediastinal Large B-Cell Lymphoma: A Single Center Experience in Korea.

Heui June Ahn, M.D., Yoo Jin Cho, M.D., Myoung Joo Kang, M.D., Dae Ro Choi, M.D., Shin Kim, Dae Ho Lee, M.D., Sang We Kim, M.D., Jung Shin Lee, M.D., Jooryung Huh, MD, Cheolwon Suh, M.D.

Blood (2009) 114 (22): 5013.

https://doi.org/10.1182/blood.V114.22.5013.5013

Published: 2009

Journal Articles

Prognostic Significance of Circulating Epstein-Barr Virus (EBV) DNA in Non-Hodgkin's Lymphoma.

Myoung Joo Kang, M.D., Yoo Jin Cho, M.D., Heui June Ahn, M.D., Shin Kim, Dae Ho Lee, M.D., Sang We Kim, M.D., Hyun-Sook Chi, M.D., Cheolwon Suh, M.D.

Blood (2009) 114 (22): 1936.

https://doi.org/10.1182/blood.V114.22.1936.1936

Published: 2009

Journal Articles

The Role of Prophylactic Antimicrobials during Autologous Stem Cell Transplantation: A Single Center Experience

Byeong Seok Sohn, M.D., Dok Hyun Yoon, M.D., Shin Kim, R.N., Dae Ho Lee, M.D., Sang-We Kim, M.D., Jooryung Huh, M.D., Jung Shin Lee, M.D., Cheolwon Suh, M.D.

Blood (2008) 112 (11): 4375.

https://doi.org/10.1182/blood.V112.11.4375.4375

Published: 2008

Journal Articles

Single and Tandem Autologous Peripheral Blood Stem Cell Transplantation for Patients with Multiple Myeloma: A Korean Multicenter Retrospective Study.

Sun Jin Sym, MD, Jae Yong Kwak, M.D., Chang Ki Min, M.D., Jong Ho Won, M.D., Seung-Tae Lee, M.D., Kihyun Kim, M.D., Cheolwon Suh, M.D.

Blood (2007) 110 (11): 5132.

https://doi.org/10.1182/blood.V110.11.5132.5132

Published: 2007

Journal Articles

A Multicenter Phase II Trial of Etoposide, Methylprednisolone, High-Dose Cytarabine, and Oxaliplatin (ESHAOx) for Patients with Refractory/Relapsed Aggressive Non-Hodgkin’s Lymphoma.

Sun Jin Sym, MD, Hye Jin Kang, M.D., Seung-Hyun Nam, M.D., Hoyoung Kim, M.D., Seok Jin Kim, M.D., Hyeon Seok Eom, M.D., Won Seog Kim, M.D., Cheolwon Suh, M.D.

Blood (2007) 110 (11): 3446.

https://doi.org/10.1182/blood.V110.11.3446.3446

Published: 2007

Journal Articles

Sequential VAD (Vincristine, Adriamycin, Dexamethasone) and VTD (VELCADE®, Thalidomide, Dexamethasone) Induction Followed by High-Dose Therapy with Autologous Stem Cell Transplantation and Maintenance Treatment with VELCADE for Newly Diagnosed Multiple Myeloma: Interim Results of Phase II Trial.

Sung-Soo Yoon, MD, Hye Jin Kim, M.D., Dong Soon Lee, M.D., Hyeon Seok Eom, M.D., Jun Ho Jang, M.D., Ju Seup Chung, M.D., Hye Jin Kang, M.D., Cheol Soo Kim, M.D., Kihyun Kim, M.D., Jae Hoon Lee, M.D., Sang Jae Lee, M.D., Yu Hong Min, M.D., Chu Myong Seong, M.D., Sang Kyun Sohn, M.D., Cheolwon Suh, M.D., Jong Ho Won, M.D.

Blood (2007) 110 (11): 952.

https://doi.org/10.1182/blood.V110.11.952.952

Published: 2007

Journal Articles

Mobilization of Peripheral Blood Stem Cells with Rituximab Plus ESHAP Combination Regimen in B-Cell NHL - Preliminary Results.

Min Kyoung Kim, MD, Shin Kim, R.N., Seong Sook Lee, M.D., Sun Jin Sym, M.D., Dae Ho Lee, M.D., Sang We Kim, M.D., Seongsoo Jang, M.D., Chan Jeong Park, M.D., Hyun Sook Chi, M.D., Joo Ryung Huh, M.D., Cheolwon Suh, M.D.

Blood (2006) 108 (11): 5443.

https://doi.org/10.1182/blood.V108.11.5443.5443

Published: 2006

Journal Articles

Treatment of Peripheral T-Cell Lymphoma (PTCL) with High-Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT).

Min Kyoung Kim, MD, Shin Kim, R.N., Seoung Sook Lee, M.D., Sun Jin Sym, M.D., Dae Ho Lee, M.D., Sang We Kim, M.D., Seongsoo Jang, M.D., Chan Jeong Park, M.D., Hyun Sook Chi, M.D., Joo Ryung Huh, M.D., Cheolwon Suh, M.D.

Blood (2006) 108 (11): 4682.

https://doi.org/10.1182/blood.V108.11.4682.4682

Published: 2006

Journal Articles

The Lymphocyte Recovery on Day +23 Correlates with Survival after Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma.

Hawk Kim, M.D., Shin Kim, R.N., M. Wookun Kim, M.D., Jung-Shin Lee, M.D., Cheolwon Suh, M.D.

Blood (2004) 104 (11): 5210.

https://doi.org/10.1182/blood.V104.11.5210.5210

Published: 2004

NARROW

The Clinical Utility of FDG PET-CT in Evaluation of Bone Marrow Involvement by Diffuse Large B Cell Lymphoma

Remobilization with High Dose Methotrexate and Cytarabine in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma Previously Failing Mobilization with Chemotherapy and Cytokine Treatment

SIGNIFICANCE of ABSOLUTE LYMPHOCYTE COUNT at RELAPSE as a PROGNOSTIC FACTOR in PATIENTS with T-CELL NON-HODGKIN'S LYMPHOMA.

Myelomatous Pleural Effusion of Multiple Myeloma: Characteristics and Outcome.

Excessive Toxicity of Once Daily Intravenous Busulfan, Melphalan, and Thiotepa Followed by Autologous Stem Cell Transplantation On Patients with Non-Hodgkin's Lymphoma.

The Role of High Dose Chemotherapy/Autologous Stem Cell Transplantation for Salvage Treatment for Relapsed Peripheral T Cell Lymphoma.

Clinical Features and Prognostic Relevance of Ovarian Involvement in Non-Hodgkin's Lymphoma: a Consortium for Improving Survival of Lymphoma (CISL) Report.

The Utility of the Follow-up with Serum Free Light Chain After Autologous Stem Cell Transplantation in Multiple Myeloma Patients with Measurable M-Protein.

Primary Mediastinal Large B-Cell Lymphoma: A Single Center Experience in Korea.

Prognostic Significance of Circulating Epstein-Barr Virus (EBV) DNA in Non-Hodgkin's Lymphoma.

The Role of Prophylactic Antimicrobials during Autologous Stem Cell Transplantation: A Single Center Experience

Single and Tandem Autologous Peripheral Blood Stem Cell Transplantation for Patients with Multiple Myeloma: A Korean Multicenter Retrospective Study.

A Multicenter Phase II Trial of Etoposide, Methylprednisolone, High-Dose Cytarabine, and Oxaliplatin (ESHAOx) for Patients with Refractory/Relapsed Aggressive Non-Hodgkin’s Lymphoma.

Sequential VAD (Vincristine, Adriamycin, Dexamethasone) and VTD (VELCADE®, Thalidomide, Dexamethasone) Induction Followed by High-Dose Therapy with Autologous Stem Cell Transplantation and Maintenance Treatment with VELCADE for Newly Diagnosed Multiple Myeloma: Interim Results of Phase II Trial.

Mobilization of Peripheral Blood Stem Cells with Rituximab Plus ESHAP Combination Regimen in B-Cell NHL - Preliminary Results.

Treatment of Peripheral T-Cell Lymphoma (PTCL) with High-Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT).

The Lymphocyte Recovery on Day +23 Correlates with Survival after Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only